Statement of Need/Target Audience
One of the most rapidly evolving areas of interest in breast cancer medicine involves the human epidermal growth factor receptor–2 (HER2). Published results from numerous studies lead to the continual emergence of new data and changes in the understanding of clinical assays of HER2. In order to offer optimal patient care, the practicing medical oncologist and pathologist must be well-informed of these advances. To bridge the gap between research and patient care, this HER2 journal club utilizes one-on-one discussions with leading oncology and pathology investigators. By providing highlights from recent publications about HER2 and the experts’ perspectives, this CME program assists medical oncologists and pathologists in incorporating up-to-date information into their clinical practice.

Learning Objectives
Upon completion of this activity, participants should be able to:

• Critically evaluate the clinical implications of the emerging data about the discordance between local and central laboratory HER2 testing
• Describe and implement an algorithm for HER2 testing
• Explain the components of a quality assurance program for HER2 testing
• Define clinical variables that should be considered when evaluating the accuracy of HER2 test results
• Assess the need to retest a patient’s HER2 status

Educational Method
To receive CME credit, the participant should listen to the CD or tape, review the monograph and complete the post-test and evaluation form.

Accreditation Statement
NL Communications Inc is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
NL Communications Inc designates this educational activity for a maximum of 2.5 category 1 credits towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent on the activity.

Faculty Disclosures
As a provider accredited by the ACCME, it is the policy of NL Communications Inc to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. Financial disclosures can be found here.